Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Boehringer Ingelheim
Boehringer Ingelheim
ADA: Lilly, BI's Jardiance cut kidney disease progression in Empa-Reg analysis
Fierce Pharma
Mon, 06/25/18 - 09:06 pm
ADA
kidney disease
Eli Lilly
Boehringer Ingelheim
5 Biggest Blockbuster Diabetes Drugs of the Future
Motley Fool
Sun, 06/24/18 - 10:04 am
Eli Lilly
Trulicity
Novo Nordisk
Ozempic
Boehringer Ingelheim
Jardiance
Tresiba
NovoRapid
Boehringer backs €20B R&D game plan with a $272M blueprint for new facility — 100 new hires
Endpoints
Fri, 06/22/18 - 10:23 am
Boehringer Ingelheim
R&D
Germany
Two drugs in the pipeline representing unique marketing challenges
Medical Marketing and Media
Tue, 06/5/18 - 10:37 pm
valrox
Biomarin
hepatitis A
risankizumab
AbbVie
Boehringer Ingelheim
psoriasis
Reversal Agent for Pradaxa, Praxbind, Now Available Nationwide
CP Wire
Fri, 05/4/18 - 06:48 pm
Boehringer Ingelheim
Pradaxa
Praxbind
Reversal Agent for Pradaxa, Praxbind, Now Available Nationwide
Fri, 05/4/18 - 10:22 am
Boehringer Ingelheim
Pradaxa
Praxbind
Pharma's social media strategies are growing up—and working better, too, report finds
Fierce Pharma
Mon, 03/26/18 - 09:34 am
social media
Novo Nordisk
JNJ
Novartis
Boehringer Ingelheim
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Fierce Pharma
Wed, 03/7/18 - 12:00 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
exercise
diabetes
Boehringer ends Alzheimer's research for PDE9 blocker
Biopharma Dive
Sat, 02/10/18 - 09:22 am
Boehringer Ingelheim
Alzheimer's disease
PDE9 blockers
BI 409306
Boehringer strikes Jardiance outcomes deal with Prime PBM
Biopharma Dive
Thu, 02/1/18 - 09:55 am
Boehringer Ingelheim
Jardiance
PBMs
diabetes
Prime Therapeutics
outcomes-based contracts
Boehringer Ingelheim inks outcomes-based contract with pharmacy benefit manager for diabetes drug
Drug Delivery Business News
Mon, 01/29/18 - 03:20 pm
Boehringer Ingelheim
PBMs
outcomes-based contracts
diabetes
Jardiance
Prime Therapeutics
Boehringer, hot on deals, adds another with Adimab collaboration
Biopharma Dive
Fri, 01/12/18 - 06:29 pm
Boehringer Ingelheim
Adimab
drug discovery
Boehringer, BeiGene enter manufacturing pact for PD-1 drug
Biopharma Dive
Thu, 01/11/18 - 11:54 pm
Boehringer Ingelheim
BeiGene
tislelizumab
anti-PD-L1
drug manufacturing
All in: Boehringer Ingelheim more than doubles its venture fund to €250M
Endpoints
Thu, 01/4/18 - 10:12 pm
venture capital
Boehringer Ingelheim
Boehringer Ingelheim inks CNS deal with Autifony
BioPharma Dive
Tue, 12/19/17 - 11:59 am
Boehringer Ingelheim
Autifony
CNS
Boehringer Ingelheim loses CFO due to disagreement on group’s strategy
GoinPharma
Sun, 12/17/17 - 11:30 am
Boehringer Ingelheim
J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefits
Fierce Pharma
Fri, 11/24/17 - 09:23 am
JNJ
Eli Lilly
AstraZeneca
Boehringer Ingelheim
diabetes
Invokana
Farxiga
Jardiance
Boehringer Ingelheim denies rumors on acquisition of Korea’s CJ Healthcare ($896m)
GoinPharma
Fri, 11/17/17 - 10:22 am
Boehringer Ingelheim
Korea
CJ Healthcare
M&A
Boehringer wins EU approval for Humira biosimilar
BioPharma Dive
Wed, 11/15/17 - 08:53 pm
Boehringer Ingelheim
Europe
Humira
biosimilars
Cyltezo
AbbVie
GlaxoSmithKline's Anoro tops Boehringer's Stiolto in head-to-head COPD tilt
Fierce Pharma
Sat, 11/4/17 - 08:44 am
GSK
Anoro Ellipta
Boehringer Ingelheim
Stiolto Respimat
COPD
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »